Skip to content

Venture

LOGO 2-01

Affiliations

Albert Einstein College of Medicine

Technologies

Therapeutic

Indication

Infectious Disease

Additional Information

Women Founded

Avalia Immunotherapies – A synthetic immunotherapy platform for self-adjuvanting vaccines, with a unique mode of action, aiming to improve clinical outcomes for cancer, allergy and infectious disease.

Avalia Immunotherapies Team:

Shivali Gulab, CEO